Clinical Trials Insight: 700028277
Latest Information Update: 08 Nov 2007
Price :
$35 *
At a glance
- Drugs Aclidinium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Almirall S.A.
- 08 Nov 2007 New trial record.